Particles for Humanity has received approval from the Institutional Review Board (IRB) at the University of Wisconsin-Madison in the United States to begin a human absorption study of PFH-VAP, a stable form of vitamin A.

Particles for Humanity has secured funding from King Philanthropies and the Mulago Foundation to test the absorption of vitamin A from PFH-VAP, a stable form of vitamin A palmitate for large-scale food fortification (LSFF) in humans.

Particles for Humanity has raised $10 million in grant funding to prepare its stable form of vitamin A (PFH-VAP) for adoption by national wheat flour fortification programs.

Particles for Humanity transforms medical tech for low-resource settings.

Encapsulated vitamin A product significantly outperforms commercial products.

Particles for Humanity, a life sciences company transforming early-stage technologies into products for people in low-resource settings, has appointed Dr. Amadou Alpha Sall and Andrew Jack to its Board of Directors.

Particles for Humanity has raised $4 million from the Bill & Melinda Gates Foundation, King Philanthropies, and the Mulago Foundation to address vitamin A deficiency in low-resource settings.

Codex Alimentarius Commission has approved the addition of Basic Methacrylate Copolymer (BMC, INS 1205) to the General Standards for Food Additives (GSFA).

Particles for Humanity, a life sciences company transforming early-stage technologies into products for people in low-resource settings, has appointed Mark Kessel as Chairman of its Board of Directors.

Particles for Humanity has received $5 million from the Bill & Melinda Gates Foundation to develop a product that has potential to help millions of people who suffer serious medical consequences from malnutrition.